Cargando…
Molecular Pathogenesis of Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are a group of clonal hematologic disorders characterized by inefficient hematopoiesis, hypercellular bone marrow, dysplasia of blood cells and cytopenias. Most patients are diagnosed in their late 60s to early 70s. MDS is a risk factor for the development of acute my...
Autores principales: | Visconte, Valeria, Selleri, Carmine, Maciejewski, Jaroslaw P., Tiu, Ramon V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Salerno
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000460/ https://www.ncbi.nlm.nih.gov/pubmed/24778995 |
Ejemplares similares
-
Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease
por: Visconte, Valeria, et al.
Publicado: (2014) -
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments
por: Pagliuca, Simona, et al.
Publicado: (2021) -
Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes
por: Nakajima, Hideaki
Publicado: (2020) -
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
por: Awada, Hassan, et al.
Publicado: (2020) -
Immunological Derangement in Hypocellular Myelodysplastic Syndromes
por: Serio, B, et al.
Publicado: (2014)